Nanobodies: new avenue to treat kidney disease

por Wanner, Nicola, Eden, Thomas, Liaukouskaya, Nastassia, Koch-Nolte, Friedrich
Publicado 2021

High-throughput drug screening allowed identification of entry inhibitors specifically targeting different routes of SARS-CoV-2 Delta and Omicron/BA.1

por Kuzikov, Maria, Woens, Jannis, Zaliani, Andrea, Hambach, Julia, Eden, Thomas, Fehse, Boris, Ellinger, Bernhard, Riecken, Kristoffer
Publicado 2022

The role of ADAM17 in the T-cell response against bacterial pathogens

por Link, Moritz Andreas, Lücke, Karsten, Schmid, Joanna, Schumacher, Valéa, Eden, Thomas, Rose-John, Stefan, Mittrücker, Hans-Willi
Publicado 2017

A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation

por Eden, Thomas, Menzel, Stephan, Wesolowski, Janusz, Bergmann, Philine, Nissen, Marion, Dubberke, Gudrun, Seyfried, Fabienne, Albrecht, Birte, Haag, Friedrich, Koch-Nolte, Friedrich
Publicado 2018

A simple, sensitive, and low‐cost FACS assay for detecting antibodies against the native SARS‐CoV‐2 spike protein

por Hambach, Julia, Stähler, Tobias, Eden, Thomas, Wendt, Dorte, Tode, Natalie, Haag, Friedrich, Tolosa, Eva, Altfeld, Marcus, Fathi, Anahita, Dahlke, Christine, Addo, Marylyn M., Menzel, Stephan, Koch‐Nolte, Friedrich
Publicado 2021

Transgenic Overexpression of the Disordered Prion Protein N1 Fragment in Mice Does Not Protect Against Neurodegenerative Diseases Due to Impaired ER Translocation

por Mohammadi, Behnam, Linsenmeier, Luise, Shafiq, Mohsin, Puig, Berta, Galliciotti, Giovanna, Giudici, Camilla, Willem, Michael, Eden, Thomas, Koch-Nolte, Friedrich, Lin, Yu-Hsuan, Tatzelt, Jörg, Glatzel, Markus, Altmeppen, Hermann C.
Publicado 2020